Medication info
Rozastat Tablet (Losartan Potassium)

Rozastat Tablet (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Ahn-Guk Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200600222 · Notified 2006.02.08 · Insurance code 650200440

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this drug is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years, an initial dose of 25 mg of this drug once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Ahn-Guk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension

  • Hypertension
  • kidney disease
View approved original text

This medication is used to manage blood pressure in patients with hypertension. It is particularly helpful in preventing and treating kidney disease in patients who have both hypertension and type 2 diabetes. Therefore, it is effective in controlling blood pressure while improving kidney damage caused by diabetes.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this drug is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years, an initial dose of 25 mg of this drug once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. If pregnancy is confirmed, this medication should be stopped immediately, and tests may be required to check the health of the fetus. This medication should not be administered to patients with severely impaired liver function, certain genetic disorders, or a history of angioedema. Elderly patients or patients with weakened kidney function, or high serum potassium levels should use this medication with caution, requiring regular blood tests and blood pressure monitoring. This medication can lower blood pressure, which may result in symptoms of hypotension or loss of consciousness; if symptoms occur, medical personnel should be notified immediately. Additionally, this medication can elevate potassium levels, so it is important not to take it with potassium supplements or medications containing potassium. Regular tests should be conducted during the use of this medication to ensure there are no abnormalities in liver and kidney function, and if symptoms arise, immediate consultation with a doctor is necessary. This medication is not recommended for breastfeeding women; if it must be taken, breastfeeding should be discontinued. Since it is a blood pressure control medication, caution is required when driving or operating machinery as dizziness may occur. Overdose can lead to hypotension and cardiac arrhythmias, so adherence to the prescribed dosage is essential, and immediate hospital visit is necessary if any abnormal symptoms occur.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 127 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree AV block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraines
  • neuroexcitation
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremors
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste abnormalities
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • increased frequency of urination
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylaxis-like syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste abnormalities
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopy
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, avoid storing it in extremely hot or cold places, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.